Moderna (MRNA) Reports Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to Moderna (MRNA) Reports Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

December 10, 2021 7:00 AM EST

Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed

Phase 2 dose-confirmation study was fully enrolled in November (N=500); preparation for Phase 3 study underway

Seasonal flu program now moving beyond quadrivalent: announcing mRNA-1011 & mRNA-1012 development candidates

Conference call to be held today at 8:00 a.m. ET

CAMBRIDGE, Mass.--(BUSINESS... More